Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             148 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 A colorectal mosaic pattern might be an endoscopic feature of collagenous colitis Cimmino, Daniel G.
2010
2 p. 139-143
5 p.
artikel
2 Active and passive smoking behaviour and cessation plans of patients with Crohn's disease and ulcerative colitis van der Heide, Frans
2010
2 p. 125-131
7 p.
artikel
3 Adalimumab dose escalation and dose de-escalation success rate and predictors in a large national cohort of Crohn's patients Baert, Filip
2013
2 p. 154-160
7 p.
artikel
4 Adalimumab for the induction and maintenance of clinical remission in Japanese patients with Crohn's disease Watanabe, Mamoru
2012
2 p. 160-173
14 p.
artikel
5 A new hand on the tiller: Taking over the editorship of the Journal of Crohn's and Colitis Egan, Laurence J.
2014
2 p. 91-92
2 p.
artikel
6 A novel NF-κB inhibitor, dehydroxymethylepoxyquinomicin, ameliorates inflammatory colonic injury in mice Funakoshi, Tohru
2012
2 p. 215-225
11 p.
artikel
7 Anti-colitis and -adhesion effects of daikenchuto via endogenous adrenomedullin enhancement in Crohn's disease mouse model Kono, Toru
2010
2 p. 161-170
10 p.
artikel
8 An unusual case of anorectal carcinoma in a patient with Crohn's disease Narilli, Piero
2010
2 p. 219-220
2 p.
artikel
9 An unusual case of Crohn's disease with unresponsive pleural exudates. Is Crohn's disease finally a systemic immunological disorder? Papathanasopoulos, Athanasios A.
2007
2 p. 116-121
6 p.
artikel
10 An unusual cause of right sided hip pain in a patient with ulcerative colitis: Iliopsoas muscle atrophia Voyvoda, Nuray

2 p. 167-168
artikel
11 A patient with ulcerative colitis and central serous chorioretinopathy—A therapeutic dilemma Geyshis, Bella
2013
2 p. e66-e68
nvt p.
artikel
12 A randomised double-blind placebo-controlled trial with Lactobacillus acidophilus La-5 and Bifidobacterium animalis subsp. lactis BB-12 for maintenance of remission in ulcerative colitis Wildt, Signe

2 p. 115-121
artikel
13 Arterial thromboembolism from aortic floating thrombus in a patient with Crohn's Disease Stordiau, Geraldine E. Murature

2 p. 169-170
artikel
14 A study in three European IBD cohorts confirms that the ATG16L1 c.898A>G (p.Thr300Ala) variant is a susceptibility factor for Crohn’s disease Büning, Carsten
2007
2 p. 70-76
7 p.
artikel
15 A unique clinical phenotype of primary sclerosing cholangitis associated with Crohn's disease Halliday, J.S.
2012
2 p. 174-181
8 p.
artikel
16 Autoimmune hemolytic anemia in a young adult with Crohn's disease and primary sclerosing cholangitis: An unusual association Kallel, Lamia
2009
2 p. 134-135
2 p.
artikel
17 Azathioprine-induced neuro-psychiatric disorders Bouguen, Guillaume
2014
2 p. 180-
1 p.
artikel
18 Can meat and protein really increase, while vegetables and fruits decrease the risk of inflammatory bowel disease? How? Qin, Xiaofa
2009
2 p. 136-
1 p.
artikel
19 Capsule endoscopy in Crohn's disease — Indications and reservations 2008 Chermesh, Irit
2008
2 p. 107-113
7 p.
artikel
20 Characterisation of enterocolitis in the piroxicam-accelerated interleukin-10 knock out mouse — A model mimicking inflammatory bowel disease Holgersen, Kristine
2014
2 p. 147-160
14 p.
artikel
21 Clinical trial: Preliminary efficacy and safety study of a new Budesonide-MMX® 9mg extended-release tablets in patients with active left-sided ulcerative colitis D'Haens, G.R.
2010
2 p. 153-160
8 p.
artikel
22 Colorectal carcinoma and preceding fistula in Crohn's disease Sobala, Anna
2010
2 p. 189-193
5 p.
artikel
23 Comparison of fracture risk between patients with ileal pouch-anal anastomosis for ulcerative colitis and the general population Christensen, Anders Mark
2014
2 p. 107-112
6 p.
artikel
24 Conception outcomes and opinions about pregnancy for men with inflammatory bowel disease Sato, Asaka
2010
2 p. 183-188
6 p.
artikel
25 Contents 2008
2 p. v-vi
nvt p.
artikel
26 Contents 2009
2 p. v-vi
nvt p.
artikel
27 Contents 2007
2 p. v-
1 p.
artikel
28 Contents list 2013
2 p. v-vi
nvt p.
artikel
29 Corrigendum to “European-evidence-based consensus on the management of ulcerative colitis: Current management” [J Crohns & Colitis 2 (2008) 24–62] Travis, S.P.L.
2008
2 p. 190-
1 p.
artikel
30 Corrigendum to “European evidence-based consensus on the management of ulcerative colitis: Special situations” [J Crohns & Colitis 2 (2008) 63–92] Biancone, Livia
2008
2 p. 191-
1 p.
artikel
31 Corrigendum to “Infliximab in paediatric inflammatory bowel disease” Vilar, P.
2008
2 p. 189-
1 p.
artikel
32 Corrigendum to “Prevalence of Inflammatory Bowel Disease in the Canton of Vaud (Switzerland): A population-based cohort study” [J. Crohn's & Colitis (2008) 2, 131–141] Juillerat, P.
2009
2 p. 140-
1 p.
artikel
33 Crohn's disease of the large bowel following diagnosis of chronic lymphoid leukaemia: A case report Triantafillidis, John K.
2013
2 p. e78-e79
nvt p.
artikel
34 Crohn's disease presenting with multiple intestinal "perforation" Köklü, Seyfettin
2010
2 p. 217-218
2 p.
artikel
35 CRP and pediatric ulcerative colitis Filik, Levent
2012
2 p. 259-
1 p.
artikel
36 Cryptogenic organizing pneumonia: A rare extra-intestinal manifestation of Crohn's disease Dinneen, Henry S.
2014
2 p. 177-178
2 p.
artikel
37 Cutaneous vasculitis in ulcerative colitis mimicking Henoch–Schönlein purpura de Oliveira, Guilherme Trudes
2013
2 p. e69-e73
nvt p.
artikel
38 Determinants of health-related quality of life in Crohn's disease: A systematic review and meta-analysis van der Have, Mike
2014
2 p. 93-106
14 p.
artikel
39 Development of pouchitis following ileal pouch-anal anastomosis (IPAA) for ulcerative colitis: A role for serological markers and microbial pattern recognition receptor genes Ferrante, Marc
2008
2 p. 142-151
10 p.
artikel
40 Development of testicular germ cell cancer following successful infliximab induction therapy for ulcerative colitis Wong, John C.T.

2 p. 162-164
artikel
41 Diagnosis of Clostridium difficile-associated diarrhea Bernal, Vanesa
2009
2 p. 137-
1 p.
artikel
42 Does fecal calprotectin predict relapse in patients with Crohn's disease and ulcerative colitis? García-Sánchez, Valle
2010
2 p. 144-152
9 p.
artikel
43 Dysplasia and colorectal cancer in a patient with ulcerative colitis and primary sclerosing cholangitis: A case report and a short review of the literature Chaparro, María
2013
2 p. e61-e65
nvt p.
artikel
44 Economic impact of combination therapy with infliximab plus azathioprine for drug-refractory Crohn's disease: A cost-effectiveness analysis Saito, Shota
2013
2 p. 167-174
8 p.
artikel
45 Effectiveness of contrast-enhanced ultrasound for characterisation of intestinal inflammation in Crohn's disease: A comparison with surgical histopathology analysis Ripollés, Tomás
2013
2 p. 120-128
9 p.
artikel
46 Effect of phenotype on health care costs in Crohn’s disease: A European study using the Montreal classification Odes, Selwyn
2007
2 p. 87-96
10 p.
artikel
47 Efficacy of Adalimumab as a long term maintenance therapy in ulcerative colitis McDermott, Edel
2013
2 p. 150-153
4 p.
artikel
48 Efficacy, tolerability, and predictors of response to infliximab therapy for Crohn's disease: A large single centre experience Sprakes, Michael B.
2012
2 p. 143-153
11 p.
artikel
49 Elevated immunoglobulin G4 level is associated with reduced colectomy-free survival in patients with primary sclerosing cholangitis and ulcerative colitis Navaneethan, Udayakumar
2013
2 p. e35-e41
nvt p.
artikel
50 European evidence-based Consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease Rahier, J.F.
2009
2 p. 47-91
45 p.
artikel
51 Expression and functional analysis of intestinal organic cation/l-carnitine transporter (OCTN) in Crohn's Disease Girardin, Marc
2012
2 p. 189-197
9 p.
artikel
52 Familial aggregation in Crohn's disease and ulcerative colitis in a Norwegian population-based cohort followed for ten years Bengtson, May-Bente
2009
2 p. 92-99
8 p.
artikel
53 Familial cases of glomerulonephritis complicating Crohn's disease Kallel, L.
2009
2 p. 125-127
3 p.
artikel
54 Fournier's gangrene complicating ulcerative pancolitis Katsanos, Konstantinos H.
2010
2 p. 203-206
4 p.
artikel
55 Genetic and environmental factors as predictors of disease severity and extent at time of diagnosis in an inception cohort of inflammatory bowel disease, Copenhagen County and City 2003–2005 Vind, Ida
2008
2 p. 162-169
8 p.
artikel
56 3g mesalazine granules are superior to 9mg budesonide for achieving remission in active ulcerative colitis: A double-blind, double-dummy, randomised trial Gross, Volker

2 p. 129-138
artikel
57 Green tea polyphenol epigallocatechin-3-gallate shows therapeutic antioxidative effects in a murine model of colitis Brückner, Markus
2012
2 p. 226-235
10 p.
artikel
58 High C-reactive protein in Crohn's disease patients predicts nonresponse to infliximab treatment Magro, Fernando
2014
2 p. 129-136
8 p.
artikel
59 How IBD patients cope with IBD: A systematic review McCombie, Andrew M.
2013
2 p. 89-106
18 p.
artikel
60 IBD patients need in health quality of care ECCO consensus Elkjaer, Margarita
2008
2 p. 181-188
8 p.
artikel
61 Immune-mediated colitis: Important to recognize and treat Pocha, Christine
2014
2 p. 181-182
2 p.
artikel
62 Immunohistochemical search for viral and bacterial antigens in Crohn's disease Magin, William S.
2013
2 p. 161-166
6 p.
artikel
63 Impact of a patient-support program on mesalamine adherence in patients with ulcerative colitis — A prospective study Moss, Alan C.
2010
2 p. 171-175
5 p.
artikel
64 Incidence of ulcerative colitis and Crohn's disease in Danish children: Still rising or levelling out? Jakobsen, Christian
2008
2 p. 152-157
6 p.
artikel
65 Increased expression of protease-activated receptor-2 in mucosal mast cells in Crohn's ileitis Christerson, Ulrika
2009
2 p. 100-108
9 p.
artikel
66 Infection-related hospitalizations are associated with increased mortality in patients with inflammatory bowel diseases Ananthakrishnan, Ashwin N.
2013
2 p. 107-112
6 p.
artikel
67 Infiximab for treatment of systemic amyloidosis associated with Crohn's disease Said, Yosra

2 p. 171-172
artikel
68 Inflammatory Bowel Disease in South Limburg (the Netherlands) 1991–2002: Incidence, diagnostic delay, and seasonal variations in onset of symptoms Romberg-Camps, Mariëlle J.L.
2009
2 p. 115-124
10 p.
artikel
69 Infliximab and adalimumab-induced psoriasis in Crohn's disease: A paradoxical side effect Iborra, Marisa

2 p. 157-161
artikel
70 Infliximab concentrations in the milk of nursing mothers with inflammatory bowel disease Grosen, Anne
2014
2 p. 175-176
2 p.
artikel
71 Instruction for Authors 2010
2 p. I-II
nvt p.
artikel
72 Instruction for Authors
2 p. I-II
artikel
73 Instruction for Authors 2008
2 p. I-II
nvt p.
artikel
74 Instruction for Authors 2009
2 p. I-II
nvt p.
artikel
75 Instructions for Authors 2007
2 p. I-II
nvt p.
artikel
76 Intestinal superinfections in patients with inflammatory bowel diseases Antonelli, Elisabetta
2012
2 p. 154-159
6 p.
artikel
77 Intravenous iron therapy restores functional iron deficiency induced by infliximab Katsanos, Konstantinos
2007
2 p. 97-105
9 p.
artikel
78 Isospora belli superinfection in a patient with eosinophilic gastroenteritis—A diagnostic challenge Navaneethan, Udayakumar
2012
2 p. 236-239
4 p.
artikel
79 Issue Contents list 2010
2 p. v-vi
nvt p.
artikel
80 Issue Contents list
2 p. v-vi
artikel
81 Issue Contents list 2014
2 p. v-vi
nvt p.
artikel
82 Issue Contents list 2012
2 p. v-vi
nvt p.
artikel
83 Limited ileo-caecal resection for localised Crohn’s disease in childhood: Clinical outcome and predictors of further surgery Cook, L.
2007
2 p. 82-86
5 p.
artikel
84 Listeria infection in patients on anti-TNF treatment: Report of two cases and review of the literature Abreu, Cândida
2013
2 p. 175-182
8 p.
artikel
85 Long-term follow-up of babies exposed to azathioprine in utero and via breastfeeding Angelberger, Sieglinde

2 p. 95-100
artikel
86 Long-term prevention of post-operative recurrence in Crohn's disease cannot be affected by mesalazine Papi, C.
2009
2 p. 109-114
6 p.
artikel
87 Long-term prognosis of patients with ulcerative colitis treated with cytapheresis therapy Takayama, Tetsuro
2013
2 p. e49-e54
nvt p.
artikel
88 Long term safety and efficacy of H1N1 vaccine in a single-center cohort of IBD patients treated with immunomodulators and/or anti-TNFα biologics Kyriakos, Nikolaos
2012
2 p. 264-265
2 p.
artikel
89 Low mannose-binding lectin (MBL) is associated with paediatric inflammatory bowel diseases and ileal involvement in patients with Crohn disease Kovacs, Marta
2013
2 p. 134-141
8 p.
artikel
90 Methotrexate-induced pneumonitis in a patient with Crohn's disease Margagnoni, Giovanna
2010
2 p. 211-214
4 p.
artikel
91 Necrotizing external otitis on a Crohn's disease patient treated with infliximab Duque, Gabriela
2010
2 p. 215-216
2 p.
artikel
92 Neurologic manifestations in inflammatory bowel diseases: Current knowledge and novel insights Zois, Christos D.
2010
2 p. 115-124
10 p.
artikel
93 NOD2 activity modulates the phenotype of LPS-stimulated dendritic cells to promote the development of T-helper type 2-like lymphocytes — Possible implications for NOD2-associated Crohn's disease Butler, Matt
2007
2 p. 106-115
10 p.
artikel
94 Non-adherence to treatment in inflammatory bowel disease in Czech Republic Cerveny, Petr
2007
2 p. 77-81
5 p.
artikel
95 Objectively measured muscle fatigue in Crohn's disease: Correlation with self-reported fatigue and associated factors for clinical application van Langenberg, D.R.
2014
2 p. 137-146
10 p.
artikel
96 Obstructing giant post-inflammatory polyposis in ulcerative colitis: Case report and review of the literature Maggs, James R.L.
2008
2 p. 170-180
11 p.
artikel
97 OCTN1 variant L503F is associated with familial and sporadic inflammatory bowel disease Lin, Zhenwu
2010
2 p. 132-138
7 p.
artikel
98 On the updated ECCO consensus guidelines for medical management of Crohn's disease Esser, Dirk

2 p. 165-166
artikel
99 Oral Crohn's disease: Is it a separable disease from orofacial granulomatosis? A review Zbar, Andrew P.
2012
2 p. 135-142
8 p.
artikel
100 Oral lichen planus after certolizumab pegol treatment in a patient with Crohn's disease Mocciaro, Filippo

2 p. 173-174
artikel
101 Patients with ulcerative colitis responding to steroid treatment up-regulate glucocorticoid receptor levels in colorectal mucosa Flood, L.
2008
2 p. 123-130
8 p.
artikel
102 Peculiar antibody reactivity to human connexin 37 and its microbial mimics in patients with Crohn's disease Koutsoumpas, Andreas

2 p. 101-109
artikel
103 Prediction of late-onset pouch failure in patients with restorative proctocolectomy with a nomogram Shen, Bo
2012
2 p. 198-206
9 p.
artikel
104 Pregnancy and IBD treatment: This challenging interplay from a patients' perspective Mountifield, R.E.
2010
2 p. 176-182
7 p.
artikel
105 Prevalence and clinical impact of endoscopic pseudomembranes in patients with inflammatory bowel disease and Clostridium difficile infection Ben-Horin, Shomron
2010
2 p. 194-198
5 p.
artikel
106 Prevalence and natural history of hepatitis B and C infections in a large population of IBD patients treated with anti-tumor necrosis factor-α agents Papa, Alfredo
2013
2 p. 113-119
7 p.
artikel
107 Prevalence and risk factors of hyperhomocysteinemia in Tunisian patients with Crohn's disease Kallel, Lamia

2 p. 110-114
artikel
108 Prevalence of Inflammatory Bowel Disease in the Canton of Vaud (Switzerland): A population-based cohort study Juillerat, Pascal
2008
2 p. 131-141
11 p.
artikel
109 Previous infliximab therapy and postoperative complications after proctocolectomy with ileum pouch anal anastomosis Eshuis, Emma J.
2013
2 p. 142-149
8 p.
artikel
110 Primary cytomegalovirus infectious colitis complicating Crohn's disease successfully treated with oral valganciclovir Subramanian, Venkataraman
2010
2 p. 199-202
4 p.
artikel
111 Psychotic reaction as a cardinal first clinical manifestation in a patient with Crohn's disease Triantafillidis, John K.
2013
2 p. e76-e77
nvt p.
artikel
112 Pulmonary abnormalities in inflammatory bowel disease Schleiermacher, Dietlind
2007
2 p. 61-69
9 p.
artikel
113 Pyoderma gangrenosum in inflammatory bowel disease: The experience at Mater Health Services' Adult Hospital 1998–2009 Polcz, Margit

2 p. 148-151
artikel
114 Recommendations for the treatment of ulcerative colitis with infliximab: A gastroenterology expert group consensus Reinisch, Walter
2012
2 p. 248-258
11 p.
artikel
115 Regression of giant pseudopolyps in inflammatory bowel disease Choi, Yong Sung
2012
2 p. 240-243
4 p.
artikel
116 Reply to Dr. Filik's letter Turner, Dan
2012
2 p. 260-
1 p.
artikel
117 Resource utilization during pediatric to adult transfer of care in IBD Bollegala, Natasha
2013
2 p. e55-e60
nvt p.
artikel
118 Retrobulbar optic neuritis associated with infliximab in a patient with Crohn's disease Ouakaa-Kchaou, Asma
2009
2 p. 131-133
3 p.
artikel
119 Risk factors for depression in the elderly inflammatory bowel disease population Long, Millie D.
2014
2 p. 113-119
7 p.
artikel
120 Risk factors for ulcerative colitis: A population-based, case–control study in Spain Sicilia, B.
2008
2 p. 158-161
4 p.
artikel
121 Risk of colorectal cancer and small bowel adenocarcinoma in Crohn's disease: A population-based study from western Hungary 1977–2008 Lakatos, Peter Laszlo

2 p. 122-128
artikel
122 Safe 6-thioguanine therapy of a TPMT deficient Crohn's disease patient by using therapeutic drug monitoring Mares, W.G.N.
2009
2 p. 128-130
3 p.
artikel
123 Serological markers are associated with disease course in ulcerative colitis. A study in an unselected population-based cohort followed for 10 years Høie, Ole
2008
2 p. 114-122
9 p.
artikel
124 Serum anti-Müllerian hormone levels are lower in reproductive-age women with Crohn's disease compared to healthy control women Şenateş, Ebubekir
2013
2 p. e29-e34
nvt p.
artikel
125 Seven years have elapsed Gassull, Miquel A.
2014
2 p. 89-90
2 p.
artikel
126 Severe esophageal Crohn's disease: Healing of lesions after 1 week therapy with infliximab Grassia, Roberto
2009
2 p. 138-139
2 p.
artikel
127 Severe psoriasis preceding diagnosis of large bowel Crohn's disease for 15years Triantafillidis, John K.
2013
2 p. e80-
1 p.
artikel
128 Sjögren's syndrome associated with Crohn's disease successfully treated with adalimumab Tursi, Antonio
2012
2 p. 263-
1 p.
artikel
129 Small bowel capsule endoscopy vs conventional techniques in patients with symptoms highly compatible with Crohn's Disease Petruzziello, Carmelina

2 p. 139-147
artikel
130 Small bowel carcinoma mimicking a relapse of Crohn's disease: A case series Baars, J.E.

2 p. 152-156
artikel
131 Stem cells as potential novel therapeutic strategy for inflammatory bowel disease Duijvestein, M.
2008
2 p. 99-106
8 p.
artikel
132 The association between Crohn's disease and desmoid tumors: A novel case and review of the literature Bungay, Anton W.
2010
2 p. 207-210
4 p.
artikel
133 The clinical implication of drug dependency in children and adults with inflammatory bowel disease: A review Duricova, Dana

2 p. 81-90
artikel
134 The debated role for thiopurines in Crohn's disease Herrlinger, Klaus R.
2014
2 p. 172-174
3 p.
artikel
135 The effect of dietary chemicals on gut bacteria and IBD demands further study Qin, Xiaofa

2 p. 175
artikel
136 The effects of NOD2/CARD15 mutations on the function of the intestinal barrier Rogler, Gerhard
2007
2 p. 53-60
8 p.
artikel
137 The IBD passport: Bridging another gap in quality of care? Muhammad, Raza
2012
2 p. 261-262
2 p.
artikel
138 The pharmacokinetic effect of adalimumab on thiopurine metabolism in Crohn's disease patients Wong, D.R.
2014
2 p. 120-128
9 p.
artikel
139 The use of Cyclosporin A in acute steroid-refractory ulcerative colitis: Long term outcomes Sharkey, Lisa

2 p. 91-94
artikel
140 Thrombosis in inflammatory bowel disease: Are we tailoring prophylaxis to those most at risk? Bryant, Robert V.
2014
2 p. 166-171
6 p.
artikel
141 Tolerability of one hour 10mg/kg infliximab infusions in inflammatory bowel diseases: A prospective multicenter cohort study Babouri, Abdenour
2014
2 p. 161-165
5 p.
artikel
142 Tolerability of one hour 10mg/kg infliximab infusions in patients with inflammatory bowel disease Babouri, Abdenour
2013
2 p. 129-133
5 p.
artikel
143 Ulcerative colitis, Crohn's disease and irritable bowel syndrome patients need fecal transplant research and treatment Brown, Amy C.
2014
2 p. 179-
1 p.
artikel
144 Ulcerative colitis presenting with Budd–Chiari syndrome Yılmaz, Bülent
2013
2 p. e74-e75
nvt p.
artikel
145 Unusual bilateral obstructive uropathy with kidney failure in an adolescent with ulcerative colitis Tkaczyk, Marcin
2012
2 p. 244-247
4 p.
artikel
146 Urinary NMR metabolomic profiles discriminate inflammatory bowel disease from healthy Stephens, Natasha S.
2013
2 p. e42-e48
nvt p.
artikel
147 Validation of a point-of-care desk top device to quantitate fecal calprotectin and distinguish inflammatory bowel disease from irritable bowel syndrome Sydora, Michael J.
2012
2 p. 207-214
8 p.
artikel
148 Vitamin D deficiency in Crohn's disease: Prevalence, risk factors and supplement use in an outpatient setting Nic Suibhne, Treasa
2012
2 p. 182-188
7 p.
artikel
                             148 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland